These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7826358)

  • 1. Physical and biological characterization of a growth-inhibitory activity purified from the neuroepithelioma cell line A673.
    Stam K; Stewart AA; Qu GY; Iwata KK; Fenyö D; Chait BT; Marshak DR; Haley JD
    Biochem J; 1995 Jan; 305 ( Pt 1)(Pt 1):87-92. PubMed ID: 7826358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucocorticoid regulation of transforming growth factor-beta activation in urogenital sinus mesenchymal cells.
    Rowley DR
    Endocrinology; 1992 Jul; 131(1):471-8. PubMed ID: 1612028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TGF beta 1 and TGF beta 2 are potential growth regulators for medulloblastomas, primitive neuroectodermal tumors, and ependymomas: evidence in support of an autocrine hypothesis.
    Jennings MT; Kaariainen IT; Gold L; Maciunas RJ; Commers PA
    Hum Pathol; 1994 May; 25(5):464-75. PubMed ID: 8200640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification and characterization of tumor inhibitory factor-2: its identity to interleukin 1.
    Fryling C; Dombalagian M; Burgess W; Hollander N; Schreiber AB; Haimovich J
    Cancer Res; 1989 Jun; 49(12):3333-7. PubMed ID: 2785851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth stimulation of human breast cancer cells with anti-transforming growth factor beta antibodies: evidence for negative autocrine regulation by transforming growth factor beta.
    Arteaga CL; Coffey RJ; Dugger TC; McCutchen CM; Moses HL; Lyons RM
    Cell Growth Differ; 1990 Aug; 1(8):367-74. PubMed ID: 2177634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transforming growth factor beta regulation of cell proliferation.
    Moses HL; Coffey RJ; Leof EB; Lyons RM; Keski-Oja J
    J Cell Physiol Suppl; 1987; Suppl 5():1-7. PubMed ID: 3316252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transforming growth factor-beta 2 is an autocrine growth inhibitory factor for the MOSER human colon carcinoma cell line.
    Levine AE; Lewis LR
    Cancer Lett; 1993 Jan; 68(1):33-41. PubMed ID: 8422647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth factor-independent proliferation of rat mammary carcinoma cells by autocrine secretion of neu-differentiation factor/heregulin and transforming growth factor-alpha.
    Ethier SP; Langton BC; Dilts CA
    Mol Carcinog; 1996 Feb; 15(2):134-43. PubMed ID: 8599580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutralizing antibodies against transforming growth factor beta potentiate the proliferation of Ki-1 positive lymphoma cells. Further evidence for negative autocrine regulation by transforming growth factor beta.
    Newcom SR; Tagra KK; Kadin ME
    Am J Pathol; 1992 Mar; 140(3):709-18. PubMed ID: 1312308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. cDNA and genomic cloning and expression of the P48 monocytic differentiation/activation factor, a Mycoplasma fermentans gene product.
    Hall RE; Agarwal S; Kestler DP; Cobb JA; Goldstein KM; Chang NS
    Biochem J; 1996 Nov; 319 ( Pt 3)(Pt 3):919-27. PubMed ID: 8921000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transforming growth factors produced by normal and neoplastically transformed rat liver epithelial cells in culture.
    Liu C; Tsao MS; Grisham JW
    Cancer Res; 1988 Feb; 48(4):850-5. PubMed ID: 3276400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A human keratinocyte cell line produces two autocrine growth inhibitors, transforming growth factor-beta and insulin-like growth factor binding protein-6, in a calcium- and cell density-dependent manner.
    Kato M; Ishizaki A; Hellman U; Wernstedt C; Kyogoku M; Miyazono K; Heldin CH; Funa K
    J Biol Chem; 1995 May; 270(21):12373-9. PubMed ID: 7539002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purification and biological properties of type beta transforming growth factor from mouse transformed cells.
    Fernandez-Pol JA; Klos DJ; Grant GA
    Cancer Res; 1986 Oct; 46(10):5153-61. PubMed ID: 3489522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The production of transforming growth factor-beta in the porcine ovary and its secretion in vitro.
    Gangrade BK; May JV
    Endocrinology; 1990 Nov; 127(5):2372-80. PubMed ID: 2226322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of wild-type p53 in human A673 cells suppresses tumorigenicity but not growth rate.
    Chen YM; Chen PL; Arnaiz N; Goodrich D; Lee WH
    Oncogene; 1991 Oct; 6(10):1799-805. PubMed ID: 1923505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activated alpha 2-macroglobulin reverses the immunosuppressive activity in human breast cancer cell-conditioned medium by selectively neutralizing transforming growth factor-beta in the presence of interleukin-2.
    Harthun NL; Weaver AM; Brinckerhoff LH; Deacon DH; Gonias SL; Slingluff CL
    J Immunother; 1998 Mar; 21(2):85-94. PubMed ID: 9551359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of recombinant human large latent transforming growth factor-beta 1 and monoclonal antibodies to it.
    Tsumura H; Ishii Y; Shimizu E; Ohashi H; Mori KJ
    Biosci Biotechnol Biochem; 2000 Jan; 64(1):17-23. PubMed ID: 10705443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TNF-alpha-induced antiproliferation is not dependent on the autocrine action of TGF-beta 1 in a thyroid cancer cell line.
    Pang XP; Yoshimura M; Wang J; Dubinett SM
    Lymphokine Cytokine Res; 1994 Apr; 13(2):93-7. PubMed ID: 8061120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Possible involvement of TGF beta 1 in the distinct tumorigenic properties of two rat colon carcinoma clones.
    Grégoire M; Garrigue L; Blottière HM; Denis MG; Meflah K
    Invasion Metastasis; 1992; 12(3-4):185-96. PubMed ID: 1338201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Partial characterization of glioma-derived growth factor 2: a novel mitogenic activity from human cell line D-54 MG.
    Lyon E; Gillespie GY
    J Neurooncol; 1993 Aug; 17(2):99-109. PubMed ID: 8145064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.